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Abstract 
 
In the last few years, several samples were found to contain different combinations of 
multiple synthetic cannabinoids, fact which may end up in a serious health threat since 
these substances are not fully studied and the toxic as well as the pharmacological effects 
are not known. The isolation and quantification of psychoactive substances from the 
herbal blends, known as ‘Spice’, was performed by HPLC-UV and the identification by 
LC-MS/MS. The HPLC-UV method was validated for the quantification and has proven 
to be fit for purpose. The sample 1 has shown the coexistence of JWH-122 (29,07mg/g) 
and JWH-210 (175,9mg/g) while the sample 2 was found to contain one single synthetic 
cannabinoid, the JWH-018 (149,7mg/g). The sample 3 presented the same multiple 
psychoactive substances as sample 1, JWH-122 (7,3mg/g) and JWH-210 (129,9mg/g). 
Since these drugs are mainly smoked, a smoking machine was created* in order to 
characterize the chemical composition of the pyrolysis.  The GC-MS analysis performed 
to the pyrolysis solutions has shown no degradation of the JWH-018, drug used for the 
assay.  The toxicity impact of the characterized substances was assessed on human 
neuroblastoma SH-SY5Y cells, applying a combination of multiple synthetic 
cannabinoids (JWH-122 and JWH-210) and single one (JWH-018). The preliminary 
results indicate that these psychoactive substances are not toxic to the cells in the 
concentrations ranging from 0µM to 50µM. 
*Designed by Dr. Alexandre Quintas and is under a patenting process 
 
Keywords: synthetic cannabinoids, JWH-018, JWH-122, JWH-210, isolation, 
quantification, HPLC-UV, LC-MS/MS, GC-MS, smoking machine, toxicity 
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1. Introduction  
Novel Psychoactive Substances (NPS) are substances which are not controlled by the 
convention from 1961 ‘Single Convention on Narcotic Drugs’ or either from 1971 
‘Convention on Psychotropic Substances’ that may result in a health threat. (UNODC, 
2013b) These are defined as ‘compounds that are formally (not synthetically) derived 
from the structure of a well-known compound’ (EMCDDA, 2012) exhibiting slight 
chemical modifications, however still similar to the basic structures of the studied 
compounds.  
On the global market over the period 2009-2013, the number of NPS more than doubled 
- by December 2013, the number of such substances reported to UNODC reached 348. 
These synthetic drugs can range from synthetic cannabinoids (known as incense or spice) 
to synthetic amphetamine-like drugs (UNODC, 2013b). The present research study is 
focused on synthetic cannabinoids, substances which have been highly reported in the 
last two years. (Figure 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1- New psychoactive substances reported to UNODC by December 2013 
(UNODC, 2014) 
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1.1.Synthetic Cannabinoids 
Back in 2008, the Europol joint with the European Monitor Centre for Drugs and Drug 
Addiction (EMCDDA) identified in herbal mixtures (so called ‘Spice’) synthetic 
cannabinoids which are defined as pharmacologically active ingredients that affect both 
cannabinoid 1/cannabinoid 2 receptors (CB1/CB2), being functionally similar to ∆-9-
deltahydrocannabinol (THC), principal molecule of cannabis (EMCDDA, 2008). The 
CB1 receptor is present mainly in the brain and spinal cord and is responsible for 
psychotropic (mood and behavior alterations due changes in chemical levels in the brain) 
and physiological effects of cannabis. The CB2 is mainly located in the cells of the 
immune system and in the spleen being able to mediate immune‐modulatory effects. 
(Porter & Felder, 2001)  
Sold from 0,5g to 3g per packet and known as well as incense or herbal blends, the first 
generation of these ‘Spice’ products had names as ‘Spice gold’, ‘Smoke’, ‘Yucatan Fire’ 
or ‘Spice silver’ (Figure 2). The highly attractive packets describe the ingredients as plant 
material (wide range of various herbs) without mentioning the addition of chemical 
additives. Some of these products state on the label that 
the herbs are able to produce similar effects to cannabis 
to make believe that the pharmacological effects are due 
to the natural constituents. With the increase of 
popularity, these products which started being 
commercialized mainly online started being available in 
physical shops, so called as ‘smartshops’ or ‘headshops’. 
(UNODC,2011) 
 
1.2.Mode of administration 
The main route of the administration of synthetic cannabinoids is usually through 
inhalation (smoking) (UNODC, 2011), being the main reason the quick absorption and 
consequent fast onset of the desired effects. These substances are present in the market as 
pills however the oral administration leads to a delayed onset of the effects due to the 
metabolism that takes place before the substance reaches the blood. The use of synthetic 
cannabinoids as tea (infusions) is not so common due to the low solubility in water. The 
administration through parenteral routes has not been described so far. 
Figure 2 - 'Spice' packet 
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1.3.Chemical classification 
Cannabis is widely considered as the illicit drug most used in developed societies. This 
all started as a consequence of THC isolation in the 1960s, when a wide range of different 
synthetic exogenous cannabinoid receptor agonists were synthesized. At that time, 
J.W.Huffman focused his research on the synthesis of THC analogues and metabolites 
initially with the purpose of studying the interaction of drugs in the brain, in order to 
develop pharmaceutical products. Later on, these substances started to be commercialized 
with a second purpose. The JWH-018, which is by far the most known synthetic 
cannabinoid and is considered to be up to three times more potent than THC, belongs to 
the aminoalkylindoles group (as most of the JWH compounds) This group is divided into 
seven considered structural groups: a) Naphthylmethylindoles (e.g. JWH-018, JWH-073, 
JWH-081, JWH-122, JWH-200, JWH-210), b) Phenylacetylindoles (e.g.JWH-250, JWH-
251), c) Benzoylindoles, d) Naphthylmethylindoles, e) Cyclopropoylindoles, f) 
Adamantoylindoles and g) Indole carboxamides.  (UNODC, 2013b) 
In addition to these substances, there are other synthetic cannabinoids, which include the 
cannabinoid produced by Raphael Mechoulam (1060s) at Hebrew University named as 
‘HU-210’ and considered the first synthetic analogue of THC. Due to its chemical 
similarity with THC, it is regarded as ‘Classical Cannabinoid’ (Figure 3). The ‘Non-
Classical Cannabinoids’ were developed by 
Pfizer in the 1970s as potential analgesics and 
are named as ‘CP’ (cyclohexylphenol). 
Alexandros Makriyannis synthesized the 
‘AM’ compounds which are other indole-
derived cannabinoids detected as well in 
many herbal products. These are considered 
as ‘Hybrid Cannabinoids’ since they 
combines features from both ‘classical’ and 
’non-classical’ cannabinoids. (Seely, 2012) 
The ‘Eicosanoids’ group are 
endocannabinoids (e.g. anandamide – AEA) 
and their synthetic analogues. (UNODC, 
2013a) 
 
Figure 3 - Chemical structure of (A) Delta-9-
THC; (B) HU-210 (UNODC, 2013b) 
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1.4.Effects 
The packages frequently state that the content is ‘not for human consumption’, however 
the belief that synthetic cannabinoids are safe, licit and non-toxic is still persistent. 
Actually, some of these compounds, considered as legal alternatives to the illegal 
cannabis, might be more powerful than the basic THC (Δ9-tetrahydrocannabinol) 
however, any safety information (doses and side effects) as well as chemical information 
(list of active pharmacological agents) is not provided due to lack of regulation (Seely et 
al., 2012). Although the cannabis adverse effects are known, the information available 
concerning the short and long-term of synthetic cannabinoid effects is limited. Although 
unreliable, nowadays the most abundant source with some of the side effects of these new 
substances is within the internet, namely in forums where the consumers exchange 
knowledge about the body reaction after its consumption. These range from 
disorientation, psychosis, sedation, delusions, agitation to tachycardia. (Lapoint et al., 
2011; Simmons et al., 2011; Zimmermann et al., 2009) 
 Due to the ever-changing cocktail blend of chemicals that characterize these substances, 
the effects in the users are not the same. Studies to assess how similar these packages 
were, found that the chemical composition (namely the presence of synthetic 
cannabinoids) was the principal variable to account for sample differentiation. Moreover, 
it was found that correlation of substances found among products takes into account the 
flavor of the herbal preparation however not the name from which is known. (Zuba et al., 
2011) This may be a potential danger since the consumers rely on the fact that the products 
with the same name end up containing the same substances. Since the user has no 
information related with the active substances present in the herbal product, this 
phenomenon should be considered as a threat since it may culminate in a series of toxic 
effects not expected by the consumer.  
 
1.5.Most relevant studies 
Along the past few years, several studies have focused on the identification and 
quantification of synthetic cannabinoids and respective derivatives in herbal products as 
adulterants (Nakajima et al., 2010; Uchiyama et al., 2010; Dunham et al., 2012) or even 
more recently, the study of their metabolites (Moran et al., 2011; Rajasekaran et al., 2013; 
Scheidweiler & Huestis, 2014), however the secondary and toxic effects hidden behind 
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these products still remain uncertain. Actually, Zuba et al. (2011) identified a range of 
active compounds present in herbal products and compared the chemical composition 
found in each one of them. Although many of these substances have been submitted to 
several studies (Nakajima et al, 2010; Durham et al., 2012; Ernst et al., 2012) and these 
are already considered illegal, there are no experiments that assess the toxicity of these in 
combination with other derived substances. 
Aggravating the situation, several studies revealed that several samples contained 
different combinations of multiple synthetic cannabinoids, which may end up in a serious 
health issue (UNODC, 2013b) since these substances are not fully studied and the toxicity 
as well as the pharmacological effects are not known (Camilleri et al., 2010). Moreover, 
the presence of multiple synthetic cannabinoids in herbal mixtures has been recurrent and 
the assessment of the toxicity inherent to the co-existence of more than one compound 
has not been studied so far. This phenomenon characterized by the multiple presence of 
different synthetic substances in herbal products has become common that countless 
studies (Uchiyama et al., 2010, 2011; Zuba et al., 2011; Choi et al., 2013) are reporting 
findings of different combinations of substances. Subsequent to this fact, Atwood et al. 
(2011) have shown that most of these new substances that nowadays are part of herbal 
blends composition, have similar or higher affinities and potencies to CB1 and CB2 
receptor when compared with the JWH-018. Although the psychoactive effects produced 
by these substances are due to this pharmacodynamic occurrence meant to mimic ∆9-
THC substance, similar affinities and potencies detected may result in higher toxicity than 
are known for pure cannabis.  
In 2011, Tomiyama & Funada (2011) studied the cytotoxicity of some synthetic 
cannabinoids (CP-55,940, CP-47,497 and CP-47,497-C8) upon NG 108-15 cells and it 
was found that these were cytotoxic to the cells (on a concentration dependent manner - 
≥75–100 μM), inducing cell apoptosis. However, this cytotoxicity was mediated mainly 
by the CB1 receptor, but not by the CB2. Later on in 2014, along with the synthetic 
cannabinoids that had been tested previously, HU-210, JWH-018, JWH-210, AM-2201, 
MAM-2201 were also added to the study, this time using mouse brain neuronal cells 
(Tomiyama & Funada, 2014). These results allowed the same conclusion to be made: the 
cytotoxicity induced (cell apoptosis) by synthetic cannabinoids was mediated by CB1 but 
not CB2 receptor, depending as well on the concentration applied. Summary, the recurrent 
use of synthetic cannabinoids may end up in neuronal cell damage.  
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1.6.Emergence of synthetic cannabinoids 
New variants of these substances are synthesized every day by clandestine laboratories in 
order to circumvent the current legislation, these being defined as ‘compounds that are 
formally (not synthetically) derived from the structure of a well-known compound’, 
exhibiting slight chemical modifications however still similar to the basic structures of 
the studied compounds (EMCDDA, 2012). This occurrence has been followed and 
discussed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
as well by the United Nations Office on Drugs and Crime (UNODC). Based on the latest 
figures obtained from last year’s report (2013), in 2012 the European Union (EU) seized 
73 new types of psychoactive substances from which 30 were synthetic cannabinoids. It 
also indicates that 84 synthetic cannabinoids in total are being monitored by EU Early 
Warning System (EWS). Europe is by far where synthetic cannabinoids are seized (Figure 
4). The emergence of these substances in Europe arose in a large scale in 2008, reaching 
its peak in 2010 when ten countries have reported these compounds (Belgium, Bulgaria, 
Croatia, Lithuania, Luxembourg, Malta, Netherlands, Slovakia, Spain and Turkey) 
(UNODC, 2013b). As dominant compounds, the ‘JWH’ series headed the list of 
compounds detected in the ‘Spice’ products. Up to 2012, JWH-018, JWH-073, JWH-250 
and JWH-081 were the most widespread synthetic cannabinoids in the market (UNODC, 
2013b).  
 
Figure 4 - NPS seizures by region, 2009 – 2012. (UNODC, 2013b) 
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1.7.Legislation 
Synthetic cannabinoids became popular due to the relative chemical dissimilarity to the 
original cannabis, what led it to being considered ‘legal’ by the users. Over the past few 
years, drugs created in laboratories as derivatives and analogues of a parent drug 
(cannabis in this case) have shown a startling rise in popularity and suddenly became one 
of the most common misused substances (NPS). However, the prohibition did not stop 
the trade of these products and it is known that the demand and use of these drugs after 
being banned by local authorities did not slow (Vandrey et al., 2012). While cannabis and 
THC are substances which are internationally controlled under international conventions 
(1961 and 1971 conventions) none of the synthetic cannabinoids are. The legal status of 
these substances are defined by each country (UNODC, 2011) and in Portugal, these 
substances were banned in 2013, later than in the other European Countries.  Efforts have 
been made in the last few years by governments around the world, which are fighting 
against the growing threat of synthetic drugs, banning their import, sale, and use. 
However, the problem lies on the chemistry behind this drugs, which seems to be capable 
to circumvent the laws by changing a single molecule and an illegal synthetic drug can 
suddenly become legal again. 
 
1.8.Methods of analysis  
The analysis of herbal blends which are suspected to contain synthetic cannabinoids 
requires an extraction technique able to extract the lipophilic compounds from the herbal 
matrix, using an organic solvent. Liquid chromatography–mass spectrometry (LC-MS) 
and gas chromatography –mass spectrometry (GC-MS) are the most used techniques to 
identify the main active compounds present in the sample. Whenever new substances are 
found (no correspondence with the spectra library), there is the need to isolate and 
characterize these compounds. The isolation of substance is commonly performed by high 
performance liquid chromatography (HPLC) (collecting the fraction that corresponds to the 
unknown peak) and the structure elucidation achieved by 1H‐ and 13C‐NMR (Nuclear 
Magnetic Resonance). This methodology is recommended by UNODC (2013a), however 
it has been used in several studies and confirmed the efficiency of the processes 
(Uchiyama et al., 2010; Nakajima et al., 2010; Zuba et al., 2011; Dunham et al., 2012; 
Ernst et al., 2012; Moosmann et al., 2013). 
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1.9.Challenges: Lack of Standards 
The current available literature about synthetic cannabinoids leads to the creation of new 
and more complex derivatives of these already studied substances by illegal laboratories. 
These slight changes performed in the chemical structure of the compound are made in 
order to circumvent the law but keep the cannabinoids-type effects. Over the last few 
years, it has been found more frequently the presence of new compounds in herbal 
products, which were not identified beforehand. Since illegal laboratories are the 
producers of these substances, they are always one step ahead from chemical companies 
due to the latter not having the capacity to produce synthetic cannabinoids standards as 
fast as new derivatives are produced. The use of reference material is required in any 
analysis in order to obtain reliable qualitative and quantitative results. The lack of 
standards of these substances might turn the identification process of these compounds 
into complex and high cost procedure. 
Moosmann et al. (2013) described a method to isolate new synthetic cannabinoids from 
herbal products with such high purity that can be used as reference material (standards). 
The substances present in the herbal blends were identified by GC-MS and isolated by a 
new flash chromatographic method, which allows the isolation of a great percentage of 
the compound. In addition, a Nuclear Magnetic Resonance (NMR) technique was used 
as complementary technique, in order to elucidate the chemical structure of the new 
substances identified previously. In a previous study, Moosmann et al. (2012) reported 
the identification of two new synthetic cannabinoids in herbal blends, with a parallel 
methodology resorting also to the isolation of the compounds to be used as own standards.  
Since it is expected that new substances will often be found and the respective standards 
are still not being commercialized, there is the need to isolate those substances and obtain 
the respective reference material. Exceeding a purity of 99%, this approach has proven to 
be fit for purpose and the isolated compounds were able to be used as a reference material.  
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1.10. Cytotoxicity 
The SH-SY5Y human neuroblastoma cell line has widely been used since these contain 
important functional and biochemical properties of neurons. The cannabinoid receptors 
present in these cells allows the investigation of synthetic cannabinoid-induced 
cytotoxicity. (Hong-rong et al., 2010) The simplicity of the MTT method as well as short 
time that is needed to obtain results, turns this assay into one of the most used assays to 
assess cytotoxicity and cell viability. It consists of a colorimetric test which measures the 
intrinsic ability of the mitochondrial dehydrogenases to reduce the MTT (yellowish color) 
to formazan (purple color). The formazan product can be detected colorimetrically and 
estimated by spectrophotometry. (Stockert et al., 2012) 
 
1.11. Pyrolysis 
The characterization of the chemical composition of some of the smoke constituents has 
been performed by Daw et al. (2014). A Borgwaldt KC smoking machine was used to 
test JWH-018, JWH-250 and AM-2201. It was found that the pyrolysis process leads to 
the production of several active pyrolysis products, which can include other synthetic 
cannabinoids -JWH-018 and JWH-122 have been formed. These reaction products, apart 
from being active, have a certain toxicity associated which at present is unidentified. 
Moreover, these products might have dissimilar affinities to CB1 and CB2 receptor and 
thus, extend or even aggravate the adverse effects. This is a single study in the pyrolysis 
content since this process has not been a search target. 
 
1.12. Aims 
In 2013, Zuba et al. (2013) presented results of a long-term study (between 2008 and 
2011) on 'legal highs' seized samples from head shops which analysis culminated in 
inconsistency of qualitative and quantitative compositions when it came to the analysis 
of identical labelled products. In this sense, the present study introduces a new component 
that might be crucial to understanding and exploring the toxicity that might be associated 
with the presence of multiple synthetic cannabinoids in the same sample. The main aim 
of this research is to study the toxicity induced on cells (human neuroblastoma SH-
SY5Y), when a combination of different synthetic cannabinoids is applied. In order to 
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explore the possibility that fact that the coexistence of two or more synthetic cannabinoids 
in the herbal products might produce higher toxicity on the cell, rather than exposed to 
just one compound. In order to achieve this, a complete process of isolation and 
identification of the synthetic cannabinoids present in the herbal blend is needed. On the 
other hand, as a second perspective of the toxicity, a smoking system was created in order 
to mimic the consumption of these compounds and characterize the chemical composition 
of the products. 
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2. Methods and Materials 
2.1.Chemicals and reagents 
The methanol used in the extraction of the substances from the herbal matrix was bought 
from VWR. The formic acid and acetonitrile (Carlo Erba) used as analytical reagents 
grade for the HPLC gradient were purchased from SigmaAldrich®. The MiliQ water used 
in the dilutions was obtained through Millipore UV Simplicity equipment (Merck 
Millipore). 
 
2.2.Samples for analysis 
A total of 3 herbal packages sold as herbal blends (Figure 5) were purchased in 
smartshops localized in Lisbon, in March of 2013, before the ban of these substances in 
Portugal. It were named as sample 1, sample 2 and sample 3. 
 
 
 
 
 
2.3.Extraction 
The extraction procedure was based on the ‘Recommended methods for the Identification 
and Analysis of  Synthetic Cannabinoid Receptor Agonists in Seized Materials’ 
(UNODC, 2013) The procedure performed up to the dryness as well as the amount of 
solvent was similar in order to compare results. 1 mg of each herbal mixture was precisely 
weighed and then extracted using an extraction solvent under sonication bath for 10 min. 
Different extraction solvents (methanol and hexane) were tested. The extraction process 
described above was performed using methanol and hexane as extraction solvents and the 
fraction concentration quantified by HPLC. The solution was passed through a 0.45 µm 
filter (Interlab) to obtain the final extract solution. In order to increase the extraction, the 
process was performed twice using a total volume of 2ml.  
  
A B C 
Figure 5 - (A) Sample 1; (B) Sample 2; (C) Sample 3 
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2.4.Isolation and quantification of substances by HPLC 
The UNODC (2013) recommends the use of LC in order to obtain the fraction containing 
the compound of interest. The isolation of the compounds was performed by HPLC 
(HITACHI LaChrom from Merck) with an UV detector (L-7400) at 315nm of 
wavelength, using LiChrospher® 100 RP-18 (5 µm) LiChroCART® 125-4 column 
bought from Merckmillipore. The analysis was carried out with a binary mobile phase, 
consisting of solvent A (0.1% formic acid in water) and solvent B (acetonitrile).  An 
elution program (1) with a linear gradient was used for the analysis of the substances, 
defined by a gradient starting at 70% A (2 min hold) to 0% A (3 min hold) at a flow rate 
of 1 ml/min (total of 30 min run). A second elution program (2) with a linear gradient was 
used for the isolation of the substances, defined by a gradient starting at 30% A (2 min 
hold) to 0% A (3 min hold), at a flow rate of 1 ml/min (total of 15 min run). Using the 
second elution program, 20 µl were injected for quantification of the substances (same 
amount used for the calibration curve) and 100 µl for isolation. Later on, the procedure 
was carried on using a semi-preparative VDSpher 100 C18-M (5 µm) 250x10mm column 
bought from VDS Optilab in order to collect larger amounts of the analyte. The scale-up 
optimization from the analytical method to the preparative method was performed using 
standard formulas (Huber & Majors, 2007) to define the flow (Figure 6) and the injection 
volume (Figure 7). The elution program (2) with a linear gradient was used (gradient 
starting at 30% A (2 min hold) to 0% A (3 min hold)), however at a flow rate of 5 ml/min 
(total of 15 min run). The integration of the peak areas was performed used the software 
Merck-Hitachi Model D-700 Chromatography Data Station Software from Merck. In 
order to use the extracts on cells, the solutions obtained were evaporated to dryness and 
re-suspended in pure dimethyl sulfoxide (DMSO)(Sigma Aldrich, USA). 
 
 
 
 
 
  
𝑉1
𝑉2
=  
𝑟1
2
𝑟2
2
 
Figure 6 - formula to calculate the flow where:  V1 - Flow column 
1; V2 - Flow column 2; r12- radius column 1; r22- radius column 2 
𝑥1
𝜋 x 𝑟1
2
=  
𝑥2
𝜋 x 𝑟2
2
 x 
1
𝐶𝐿
 
Figure 7 - formula to calculate the volume injected where:  X1 – 
max. volume column 1; X2 – max. volume column 2; r12- radius 
column 1; r22- radius column 2; CL – ratio lengths of columns 
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2.5.Evaporation to dryness 
A sample was chosen for this optimization procedure. The extraction described above 
was performed and the total volume obtained divided in three equal aliquots. One of the 
aliquots was chosen to go under the lyophilization, other through rotary evaporator and 
another through nitrogen stream. The lyphilization required the samples to be frozen at -
80ºc before the process, which was carried using a Modulyo Freeze Dryer from Thermo 
Electron Corporation at an average of -47ºC and 200 mbar. No pre-treatment of the 
sample was needed for the nitrogen stream as well as for the rotary evaporator used was 
a Heidolph Laborota 400ºC at an average temperature of 60ºC and.  
 
2.6.Calibration curve 
Two calibration curves were performed using a JHW-018 standard. The calibrations 
solutions were prepared with acetonitrile, containing 0, 5, 10, 15, 20, 25, 30, 35 and 40 
µl/ml. Each calibrator was injected in triplicate.  
 
2.7.Method validation 
The accuracy (bias), precision (intra- and inter-assay precision), linearity, limit of 
detection (LOD) and limit of quantification (LOQ) were evaluated in order to validate the 
analytical method. The two calibration curves were performed on two successive days in 
order to access the accuracy as well as the precision (intra- and inter-assay precision). 
The accuracy and precision were compared with the acceptance criteria (<20 % 
coefficient of variation for the precision and <±20 % for bias). Nine different calibrators 
were used in each calibration curve (being five the minimum recommended amount of 
calibrators), being the linearity assed from this data set. (STGTOX, 2013) 
 
2.8.Identification of substances by LC-MS 
The identification of the compounds was performed by liquid chromatography–mass 
spectrometry (LC/MS/MS) (LC - Waters 2795  MS - Waters Quattro micro) using an 
XTerra MS C18, 5 µm 2.1 x 150 mm column brought from Waters Quattro micro. The 
solution that was injected was made of 10µl of the sample and 50µl of internal standard 
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(deuterated standard JWH-018-d3 1 µg/mL), reconstituted in 200 µL of mobile phase 
(initial composition). The analysis was carried out with a binary mobile phase, consisting 
of solvent A (0.1% formic acid in water) and solvent B (acetonitrile). A linear gradient 
was used for the analysis of the substances, defined by a gradient starting at 25% A (1 
min hold) to 80% A (13,5 min hold) and then decreasing to 25% A (3min hold) at a flow 
rate of 0,3 ml/min (total of 30 min run). The tandem mass spectrometry (MS/MS) analysis 
was performed in full scan from 0 to 500m/z in ESI mode.  
 
2.9.Pyrolysis 
Taking into account that smoking is the main route of administration of synthetic 
cannabinoids, a smoking system was created (Figure 8) in order to characterize the 
chemical composition from the pyrolysis products. With the purpose of mimicking the 
lungs, which are mainly constituted by water, an aqueous solution was used (Milipore 
water) as well as a methanolic solution to retain the lipophilic compounds.  
For this experiment, it was used purified JWH-018 from sample 2, having methanol as 
solvent. The identification of compounds present in both solutions was performed on a 
GC-MS Agilent 6890A coupled with a MS detector Agilent 5973N using two spectra 
libraries, PMW_TOX2.L and SWGDRUG.L. The separation was done using an HP-5MS 
5% phenyl methyl siloxane. The initial column temperature was set at 80ºC and was 
increased at a rate of 10ºC/min to 290ºC and help during 15min, with a total run time of 
37min. 2µl of sample were injected using the automatic injector Agilent 7683 in the split 
mode (6:1) with the transfer line temperature set at 280ºC. The MS was operated under 
EI in full scan (50 to 550 m/z). For the GC-MS analysis the water solution was evaporated 
to dryness using the rotary evaporator and re-suspended in methanol.   
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2.10. Cell Culture 
The Human Neuroblastoma-Glioma (SH-SY5Y cell line), kindly provided by Dr. Tiago 
Outeiro, Cell and Molecular Neuroscience unit, Instituto Medicina Molecular, were 
cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Sigma Aldrich, USA) 
supplemented with 10% Fetal Bovine Serum (PAA Laboratories GmbH, Austria), L-
glutamine 2mM, Penicillin 100U/ml, Streptomycin 0.1mg/ml (all from Sigma Aldrich, 
USA). The PBS (phosphate buffered saline) (Fisher Scientific) was diluted to the 
physiological concentration using double distilled, filtered through 0.2μm (Orange 
Scientific Filters) water in sterile environment. 
 
2.11. MTT Assay 
After 24h of cell grown, the cells were exposed to 10, 25 and 50mM of the drugs being 
studied, in a 0,2%DMSO (VWR). After 24h incubation in optimum conditions (37ºC; 
humidified atmosphere, 5% CO2), the medium is removed from each well of the 
microplate and each well is washed with DMEM to remove all traces of the test 
compounds. MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium solution (MTT) 
was prepared at a concentration of 0,5mg/ml in culture medium and 200ul of this MTT 
solution was added to each well and each plate was incubated for 2,5 hours under the 
same standard conditions. After incubation, the MTT solution was removed and each well 
washed with 50 µl of PBS solution 1x. After washing with PBS, 200 µl of DMSO 
Figure 8 - Smoking system (non-steril environment). (1) Pump, (2) Security valve, (3) Methanol, (4) 
Water, (5) Heating blanket + volumetric flask with herbal blend 
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(Dimethyl sulfoxide) solution was added to each well to dissolve the formazan crystals 
formed. Negative and positive controls were performed, being part of the negative control 
the cells with medium (without the drug) and an equivalent amount of solvent 
(0,2%DMSO) while the positive control was 0,1%Triton X-100 (Sigma Aldrich, USA). 
The plate was analyzed at 595nm under a microplate reader. The % of reduced MTT can 
be calculated dividing the absorbance mean of the sample by the negative control, then 
multiplying by 100 times. 
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3. Results and Discussion 
3.1.Samples for analysis 
The samples bought were suspected to contain synthetic cannabinoids in a random 
smartshop. Bought as herbal incenses, the packages advertised that was only for domestic 
use. All three stated the supposed main herbal compounds (e.g. coconut leaf, damiana, 
camomile) that they were produced in European Union (EU), however no further details 
were given. 
 
3.2.Extraction 
From the solvents tested, methanol was the solvent chosen as the extraction solvent. Apart 
from being a hazardous solvent, hexane did not achieve as good recovery percentages in 
the extraction procedure as methanol (50% less). 
The extraction procedure was done right before the analysis in order to proceed with an 
accurate quantification of the compounds, taking in to account the possibility instability 
of the solutions (e.g. degradation of the compounds along the time). Multiple extractions 
performed to the same original sample tend to give better yields. Taking into account the 
ratio herbal matrix:solvent used (100mg:1ml) for the first extraction, the solvent may 
saturate and only a fraction of the total sample is recovered. This may explain the 
extraction of still a third of the total amount while performing the second extraction. For 
the same reason, a third extraction might increase the final yield, allowing a total recovery 
from the original sample. On the other hand the time of exposure to the vortex or/and the 
sonic bath might another variable that should be taken into account.  
On the other hand the time of exposure to the vortex or/and the sonic bath might be 
another variable that should be taken into account. A longer exposure to these may 
promote the extraction of compounds from the herbal matrix and increase the overall 
recovery percentage. 
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3.3.Isolation and quantification of substances by HPLC 
During the isolation process, it was found that both sample 1 and sample 3 presented two 
close peaks while sample 2 presented one single peak (Figure 18).Chromatograms from 
different aliquots obtained along the time, from the same sample, shown differences in 
the intensity of peaks. The chromatograms (A) refer to the first extraction performed and 
the chromatograms (B) refer to an extraction performed around one month later. In 
sample 1 (Figure 9), the ratio between peaks (I) is 0,60 and (II) from sample 1 (A) and 
(B) is 0,61 while the ratio among sample 2 (A) and (B) is 1,83. The main cause of these 
area differences might be related with the sampling process since the extraction process 
was the same (analyte, extraction solvent, time of exposure to vortex and sonication bath). 
The heterogeneity of the herbal blends turns the sampling process a crucial step to achieve 
some sort of consistency in results. Turn the herbal blend into powder could allow a better 
homogeneity of the sample, however, the conservation of this material during long 
periods might need to care since it can be exposed to humidity and some of the 
compounds may deteriorate (oxidize).  
 
 
Figure 9 - HPLC chromatograms of Sample 1 (A) Primary data; (B) Secondary data 
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On the other hand, factors related with the HPLC equipment may affect the resolution of 
the separation. The resolution of the column tends to decrease with the use which can end 
up in a poorer separation of the compounds. Moreover, the collection of the purified 
fractions was made manually, which can lead either to a loss of analyte collected or the 
collection of a co-eluent peak. The low recovery percentages obtained might be strongly 
related with this fact, the manual collection of the fraction can lead to a great loss of the 
analyte to be collected. The best recovery percentage was achieved from sample 1 
(20,51%), followed by sample 2 (14,97%) and sample 3 (13,73%). Not only the isolation 
process of a substance takes into account the loss of analyte in order to get this purified 
and avoid adjacent compounds, the extraction process might introduce a relative loss of 
compound. 
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Figure 10 - HPLC chromatograms of Sample 1 (A) Primary data; (B) Secondary data 
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Not least, it has to be taken into account that the HPLC reads in a single wavelength, 
being only possible to detect compounds which are read at the wavelength used. An UV 
spectra of the JWH-018 standard (Figure 11) was performed using a Jasco V-530 UV/VIS 
spectrophotometer in order to get the wavelength at which it reaches the maximum 
absorbance. This was found to be 315nm which means that all the other compounds which 
do not have the ability to absorb at this wavelength, are not detected. Subsequently to this, 
additional compounds may be present in the run without being detected and the isolation 
might compromised. Although the fractions collected were injected to confirm the 
presence of just one peak in the chromatogram), the purity of the analyte could not be 
determined. 
 
Figure 11 - UV spectra of JWH-018 
 
The quantification was performed using the calibration curve with higher correlation 
value (R² = 0,9982) (Figure 12). In order to minimize possible negative effects from peak 
broadening, the peak area was used to determine the concentration of the substance being 
analyzed. To avoid extrapolation, the solutions were diluted in order to fit on the 
calibration curve. The content of synthetic cannabinoids has shown to be characterized 
by a wide range of concentrations, from 7,3mg/g to 176,6mg/g taking into account that 
the packages usually contain 1g of herbal mixture. The sample 1 has shown to contain 
29,07mg/g of JWH-122 and 175,9mg/g of JWH-210, sample 2 contained 149,7mg/g of 
JWH-018 while sample 3 contained 7,3mg/g of JWH-122 and 129,9mg/g of JWH-210.  
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Figure 12 - Calibration curve (1) using JWH-018 standard 
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Figure 13 - Calibration curve (2) using JWH-018 standard 
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These values are an alert to the wide range of concentration of synthetic cannabinoids that 
might be present in the herbal products which comply with several studies that quantified 
synthetic cannabinoids in ‘Spice’ products, ranging from 1,1mg/g up to 303mg/g 
(Uchiyama et al., 2010; Nakajima et al., 2011; Dunham et al., 2012; Ernst et al., 2012; 
Valoti et al., 2012; Langer et al., 2013). 
The concentrations values obtained are an approximation due to several factors. Even 
though the software performs the integration of the peaks to obtain the area, this step 
frequently has to be adjusted manually, which inserts a random error to the measurement. 
On the other hand, an internal standard calibration (e.g. JWH-018 d3) would have been 
relevant taking into account the complex matrix that is the herbal mixture, however the 
respective standard was not available. Lastly, the calibration curve used to calculate the 
concentration of all the compounds was performed using the JWH-018 standard, since no 
other standards were available. Due to this fact, the quantification of substances as JWH-
122 and JWH-210 might not be accurate.  
These results warn to the problem of multiple presence of synthetic cannabinoids in the 
same sample. The lack of toxicological studies and the possible mixtures are might be 
done may be potential harmful to the consumer, not only just because of the wide 
concentration range that these synthetic cannabinoids might present in the packages as 
well as the wide variety of substances that might present simultaneously. 
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3.4.Evaporation to dryness - optimization  
The lyophilization technique (56% recovery) has shown to be time consuming and the 
recovery percentage was not profitable. On the other hand, the nitrogen stream (52% 
recovery) revealed to be time consuming as well expensive taking into account the 
amount of gas needed for a unique evaporation. Finally, the rotary evaporator (68%) using 
methanol as solvent was found to be the best procedure to concentrate the purified 
compound, achieving a higher recovery percentage in a relative short time procedure.  
 
3.5.Method Validation 
The quantification method of JWH-018 in herbal blends by HPLC-UV was validated. 
The parameters of the validation were calculated using Microsoft Excel 2010 (Version 
14.0.7106.5003). From the two calibration curves performed, it was used the data set from 
the calibration curve with better correlation value (R² = 0,9982), being the method linear 
over the whole range of calibrators considered (0, 5, 10, 15, 20, 25, 30, 35, 40, 45 µg/mL). 
Using Grubb’s test to detect potential outliers, it was found that the null hypothesis for 
Grubbs' outlier test is that there are no outliers in the data set. The limit of detection (LOD) 
was determined as 1,56µg/mL while the limit of quantification (LOQ) was 15,57µg/mL. 
The repeatability (within-run precision) was calculated from the calibration curve with 
better correlation value (R² = 0,9982). The %RSD obtained was 2,24%, 4,16% and 12,6% 
respectively for low (5µg/ml), medium (20µg/m) and high (35µg/m) concentration, 
values which are in compliance with the criteria (<20% RSD). The intermediate precision 
(between-run) was calculated from both calibration curves performed since they were 
performed in different days. The %RSD obtained was 3,71%, 2,8% and 7,05% 
respectively for low (5µg/ml), medium (20µg/m) and high (35µg/m) concentration, 
values which are in compliance with the criteria (<20% RSD). Beyond the experimental 
error associated with any laboratory experiment due to the systematic errors (namely from 
micropipettes), the lack of more accurate results might also be due to human errors 
(random errors), since the injections were made manually. 
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3.6.Identification of substances by LC-MS 
The qualitative analysis was carried out at the Laboratório de Análises de Dopagem 
(LAD) in Lisbon. Usually the LC identification is performed by comparison of the 
retention time of the standard with the retention time of the analyte, however no standards 
were available. The identification of the substances was made by comparison of the mass 
transitions (molecular ion → product ion 1; product ion 2; product ion 3; etc;) with 
literature references (Table 1). 
 
Table 1 – Major ions for selected synthetic cannabinoids. (Kneisel, S. and Auwärter, V., 2012). 
Analyte Protonated molecular ion (m/z) Fragment ion (m/z) 
JWH-018 342.2 155.1 
 127.1 
JWH-122 356.2 169.1 
 141.1 
JWH-210 370.2 183.1 
 155.1 
  
 
In the sample 1 (Figure 19) and 3 (Figure 24) the ions at m/z 356.27 and 370.31 were 
identified as the protonated molecular ions [M+H]+ of JWH-122 and JWH-210, 
respectively (Table 1). The fragmentation ions obtained through MS/MS at m/z 356.27 
(m/z 141.08 and 169.12) were compatible with JWH 122 (Figure 20 and Figure 25). The 
fragment ion at m/z 141 is due to 2-methylnaphthalene fragment while a fragment at m/z 
169 corresponds to 6-methylnaphthalene-2-carbaldehyde. The present at m/z 370.31 (m/z 
183.11 and 155.1) were compatible with JWH 210 (Figure 21 and Figure 26), from which 
the base peak at m/z 183 corresponds to [M-186]+ due to the loss of 1-phenyl-1H-indole 
fragment (-C13H17N, -186 Da). The fragment ion at m/z 155 is due to 2-ethylnaphthalene 
fragment.  
The molecular ion 342.29 was identified in the sample 2 (Figure 22), which fragmentation 
m/z 342.29 (m/z 155.08 and 127.19) corresponds to JWH 018 (Figure 23). In this case, 
the fragment ion at m/z 155 is due to naphthalene-2-carbaldehyde and the m/z 127 to the 
single naphthalene fragment. Although the fragment ion m/z 155 is common to the JWH-
018 and JWH-210, the molecules correspondents are not the same. Although this ion is a 
specific ion from the structural point of view, cannot be used as specific taking into 
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account just the m/z value. Due to this, the identification is done based on the fragment 
ion m/z 127 and on the molecular ion m/z 342. 
The fragment at m/z 214 is common to all these three compounds due to the presence of 
1-phenyl-1H-indole-2carbaldeheyde (C14H17NO), reason why is not considered as a 
specific ion.  
All the substances found in the herbal products are known to mimic the pharmacological 
activity of the cannabinoids and taking into account the co-presence of multiple active 
compounds in the same products, it may culminate in a health problem.  Actually, these 
synthetic cannabinoids found in the herbal blends were already studied by J. W. Huffman, 
namely the receptor affinities with the receptors CB1 and CB2. JWH-122 and JWH-210 
are both analogues of JWH-018. It was stated that JWH-018 has a Ki (nM) of 9 ± 5 (CB1) 
and 2.9 ± 2.6 (CB2) while JWH-122 and JWH-210 have as Ki (nM) values of 0.69 ± 0.5 
(CB1) and 1.2 ± 1.2 (CB2) and 0.46 ± 0.03 (CB1) and 0.69 ± 0.01 (CB2) respectively - 
data reported as mean values ± SEM (standard error of the mean) (UNODC, 2011). 
Considering the Δ9- THC as a reference, all these synthetic substances have higher 
binding affinities with both cannabinoid receptors that the original molecule. This 
increased potency is might be related with an increased likelihood of adverse effects or 
even cause overdose incidents. 
 
3.7.Pyrolysis 
A smoking system was used to characterize the products from the pyrolysis of JWH-018, 
retained in methanol and water solutions. The JWH-018 was burnt as having methanol as 
solvent. The qualitative analysis as well as the identification of the compounds was done 
by GC-MS, carried out at the Instituto Nacional de Medicina Legal (INML) in Lisbon.  
The methanolic solution (Figure 14) has shown to retain more compounds than the 
aqueous solution (Figure 15). From the innumerous pyrolysis products detected, the 
search against the library identified caffeine and the synthetic cannabinoid JWH-018 in 
both methanolic and aqueous solutions. From these results it is also possible to conclude 
that caffeine is an ingredient present in the sample 2. These compounds should not be 
taken into consideration as products of pyrolysis but as not degraded compounds. 
Actually, caffeine was already reported as an additive substance to be added with the 
synthetic cannabinoids (Dresen et al., 2010, Grigoryev et al., 2011) 
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It would be expected to get degradation products of JWH-018 since the heat induced 
should lead to the cleavage of the molecule bonds. The occurrence of not degraded 
compounds might be due to an incomplete pyrolysis which can occur from not achieving 
the optimum temperature for the pyrolysis. It is stated that the heating blanket may reach 
400ºC, however there is no panel indicating the temperature that the device is operating.  
Beyond the caffeine and the JWH-018 substance, phthalates were also identified. These 
may have origin in plastic hoses (used to link the devices in the smoking system) or in 
the solvent used, namely the methanol which is from analytical grade and actually sold 
in plastic bottles. Although there are various compounds which were not identified (no 
correspondence with the library), it is not expected to reach the same results as Daw et al 
(2014) who obtained other synthetic cannabinoids as result of pyrolysis products.  
 
 
  
Figure 14 - Chromatogram from the aqueous solution 
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3.8.MTT assay – toxicological impact 
The cytotoxic test was performed using the drugs found in the herbal blends analyzed. 
Purified JWH-018, JWH-122 and JWH-210 were applied to the cells, being the latters 
applied simultaneously and in the same proportions as it was found in the sample 1.  
Taking into account that the total amount of formazan produced is proportional to the 
number viable of cells, it is shown that the number of viable cells did not decrease in 
contact with the drug within the concentration range studied (FIGURES).  Actually, both 
assays have shown the tendency the number of viable cells has shown general tendency. 
In both toxicological assays, the results indicate that these psychoactive substance are not 
toxic to the cell in the concentrations used.  
Figure 15 - Chromatogram from the methanolic solution 
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The results obtained from the MTT assay were not conclusive since this is just a 
preliminary analysis. Further assays should be performed in order to get a supportive 
result and reliable conclusions.  
 
 
 
 
 
 
Figure 16 - Cytotoxic evaluation of JWH-018 on SH-SY5Y cells. 
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Figure 17 - Cytotoxic evaluation of JWH-122 and JWH-210 on SH-SY5Y cells. 
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4. Conclusions 
 
In terms of optimization, the methanol has shown to be more efficient as extraction solvent when 
compared with hexane and the rotary evaporator the most effective method to evaporate to dryness 
taking into account factors as time, cost and recovery percentage when compared with the 
lyophilization and the nitrogen stream. The data acquired for the present HPLC-UV method to 
detect and quantify synthetic cannabinoids proved to be within the acceptable limits (criteria) and 
the method has proven to be fit for purpose. The method was validated over a concentration range 
of 0-45µg/ml and the samples quantified. The isolation and consequent quantitative analysis by 
HPLC allied with the identification of the compounds by LC-MS/MS. The sample 1 it has shown 
the coexistence of JWH-122 (29,07mg/g) and JWH-210 (175,9mg/g) while the sample 2 was found 
to contain the synthetic cannabinoid JWH-018 (149,7mg/g). The sample 3 presented the same 
multiple psychoactive substances as sample 1, JWH-122 (7,3mg/g) and JWH-210 (129,9mg/g). 
Since these drugs are mainly smoked, a smoking machine was created in order to characterize the 
chemical composition of the pyrolysis.  From the GC-MS analysis performed to the pyrolysis 
solutions has shown no degradation of the JWH-018 or degradation in the same fragments that 
appears in the mass spectra. Phthalates compounds were found, which may be derived from the 
plastic hoses or from an impure solvent that was used. The preliminary results obtained from the 
two toxicity assays performed on human neuroblastoma SH-SY5Y cells, one applying a 
combination of multiple synthetic cannabinoids (JWH-122 and JWH-210) and a second one testing 
the toxicicty of JWH-018 itself) indicate that these psychoactive substance are not toxic to the cells 
in the concentrations ranging from 0µM to 50µM.  
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5. Recommendation for further work 
 
It is known that NPS are a threat for the public heath since these are not known or fully described. 
This approach aims to have a comprehensive characterization of the unknown substances present 
in the herbal blends, from the isolation up to the toxicity impact that they might have. The present 
methodology, which includes isolation and identification of the synthetic cannabinoids and 
assessment of toxicological impact should be carried by the competent authorities in order to control 
and characterize the psychoactive substances present in Portugal. 
 
The approach presented should be developed and validated in order to get better and more 
accurate results, either in the identification of a wider range of substances or in a better 
accurate and realistic toxicological impact. In future studies when it comes to quantifying 
synthetic cannabinoids, it is recommended further optimization of the extraction process 
in order to increase the overall yield. Cytotoxic studies should be carried on, adding 
variables to the study the time of exposure of the drug to the cell, the concentration range 
used or even the number of synthetic cannabinoids applied simultaneously. Perform these 
studies taking into account the different classes of synthetic cannabinoids would be 
interesting in order to evaluate if there is some association between the drug classes and 
toxicities.  
Allying epidemiological with toxicological research would allow to assessing the 
dimension of this phenomenon. Further studies taking into account metabolites of these 
substances should be taken into account since the metabolism of these compounds is 
unknown.  Apart from the toxicity that might be detected along the metabolism of these 
compounds, a deeper knowledge about specific metabolites can lead to a faster and easier 
screening of the consumption of these drugs. 
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7. Appendices 
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Figure 18 - HPLC-UV chromatograms of the three different samples 
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Figure 19 - Full MS spectra from the sample 1, containing the molecular ion at m/z 356.2 (JWH-122) and 
m/z 370.3 (JWH-210) 
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Figure 20 - Mass spectra of the fragmentation ions at m/z 356.2 (JWH-122) 
JWH-122 
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Figure 21- Mass spectra from the fragmentation of the precursor ions m/z 370.3 (JWH-210) – Sample 1 
JWH-210 
40 
 
  
Figure 22 - Full MS spectra from the sample 2, containing the molecular ion at m/z 342.2 (JWH-018) 
41 
 
  
JWH-018 
Figure 23 - Mass spectra from the fragmentation of the ion at m/z 356.2 (JWH-018) – Sample 2 
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Figure 24 - Full MS spectra from the sample 3, containing the molecular ion at m/z 356.2 (JWH-122) 
and m/z 370.3 (JWH-210) 
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JWH-122 
Figure 25 - Mass spectra from the fragmentation of ion at m/z 356.2 (JWH-122) – Sample 3 
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JWH-210 
Figure 26 - Mass spectra from the fragmentation at m/z 370.3 (JWH-210) – Sample 3 
